Kate Haviland is COO at Blueprint Medicines Corp (BPMC). They have made 29 open-market trades across 1 company since 2017, most recently 2025-07-17.
CIK 0001663022
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $48K since 2022, against 28 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BPMC | 295,139 | $38.2M |
Shares reported on the most recent Form 4, priced at the 2025-07-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL · 10b5-1 | 2025-04-01 | 2025-04-03 | $86.55 | $268K | -4.7% | +19.1% | +49.9% |
| BPMC | SELL | 2025-03-05 | 2025-03-07 | $88.80 | $2.9M | +5.7% | -6.3% | +49.4% |
| BPMC | SELL · 10b5-1 | 2025-01-21 | 2025-01-23 | $110.24 | $319K | -1.2% | -19.4% | -25.2% |
| BPMC | SELL · 10b5-1 | 2024-11-29 | 2024-12-03 | $96.66 | $396K | -3.0% | -9.2% | -6.5% |
| BPMC | SELL | 2024-03-07 | 2024-03-11 | $90.69 | $2.3M | +1.0% | +1.5% | +16.7% |
| BPMC | SELL | 2023-03-06 | 2023-03-08 | $45.70 | $597K | +3.2% | -3.4% | +32.1% |
| BPMC | BUY | 2022-11-03 | 2022-11-07 | $43.98 | $48K | -1.9% | +8.0% | +5.3% |
| BPMC | SELL | 2022-03-03 | 2022-03-08 | $58.72 | $325K | +17.5% | +23.4% | +4.6% |
| BPMC | SELL · 10b5-1 | 2021-12-13 | 2021-12-15 | $98.30 | $98K | +3.6% | -25.3% | -43.9% |
| BPMC | SELL · 10b5-1 | 2021-09-13 | 2021-09-15 | $99.94 | $100K | +2.3% | -3.7% | -4.9% |
| BPMC | SELL | 2021-06-28 | 2021-06-30 | $90.11 | $146K | -6.0% | -0.1% | +18.0% |
| BPMC | SELL · 10b5-1 | 2021-03-15 | 2021-03-17 | $105.60 | $106K | -12.0% | -9.0% | -19.4% |
| BPMC | SELL | 2021-03-04 | 2021-03-05 | $86.69 | $328K | +10.7% | +4.9% | -9.4% |
| BPMC | SELL · 10b5-1 | 2020-11-16 | 2020-11-18 | $100.27 | $41K | +11.3% | +30.2% | -1.8% |
| BPMC | SELL | 2020-10-16 | 2020-10-20 | $101.47 | $1.7M | -0.6% | -6.0% | -0.5% |
| BPMC | SELL | 2020-09-22 | 2020-09-24 | $85.49 | $537K | +10.6% | +18.1% | +42.5% |
| BPMC | SELL | 2020-03-09 | 2020-03-11 | $51.98 | $35K | +6.0% | +32.0% | +51.7% |
| BPMC | SELL | 2020-01-10 | 2020-01-14 | $85.16 | $1.3M | -15.2% | -17.2% | -17.1% |
| BPMC | SELL · 10b5-1 | 2019-08-19 | 2019-08-21 | $85.00 | $8K | -7.2% | +1.4% | -3.3% |
| BPMC | SELL | 2019-07-16 | 2019-07-18 | $95.60 | $117K | -0.6% | -17.5% | -25.3% |
| BPMC | SELL | 2019-07-16 | 2019-07-18 | $95.47 | $150K | -0.6% | -17.5% | -25.3% |
| BPMC | SELL | 2019-06-17 | 2019-06-19 | $96.26 | $1.1M | -1.1% | -0.3% | -17.4% |
| BPMC | SELL | 2019-06-17 | 2019-06-19 | $96.46 | $1.2M | -1.1% | -0.3% | -17.4% |
| BPMC | SELL | 2019-03-01 | 2019-03-05 | $85.05 | $1.8M | +2.1% | -2.1% | -12.4% |
| BPMC | SELL | 2019-03-01 | 2019-03-05 | $85.05 | $1.8M | +2.1% | -2.1% | -12.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.